Born as a UGent spin-off in 2018, Avroxa has become a key industrial partner for the development and production of biocompatible polymers, both in R&D and cGMP quality.
Through our distinct product lines, we deliver the optimal polymer for drug, biologics and gene formulation, nanomedicines, ADCs and more.
Our Ultroxa® polymers constitute an ideal PEG replacement, with many additional benefits and functionalities, while our UltraPEI® polymers enable effective transfection and delivery of nucleic acids -both RNA and DNA-.
Click here to know more!